Premium
What psychotherapists should know about pharmacotherapies for bipolar disorder
Author(s) -
Goldberg Joseph F.
Publication year - 2007
Publication title -
journal of clinical psychology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.124
H-Index - 119
eISSN - 1097-4679
pISSN - 0021-9762
DOI - 10.1002/jclp.20362
Subject(s) - tolerability , psychology , bipolar disorder , psychotherapist , mood , psychiatry , clinical trial , clinical practice , adverse effect , medicine , pharmacology , physical therapy
This article provides a practice‐friendly overview of current psychotropic agents used for the treatment of bipolar disorder. The author reviews definitions and concepts about mood stabilization according to the evidence base, in turn profiling a “clinical niche” for lithium, anticonvulsant drugs, atypical antipsychotics, and antidepressants. Results from randomized clinical trials are summarized to help clinicians individualize treatment decisions and tailor them to real‐world patients. Recognition and management of common adverse effects are discussed alongside risk–benefit strategies to guide optimal treatment that balances clinical efficacy with drug safety and tolerability. © 2007 Wiley Periodicals, Inc. J Clin Psychol: In Session 63: 475–490, 2007.